Company Description : A biopharmaceutical company that discovers, develops and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. url: www.regeneron.com
Cellectis to receive $12.45 million upfront from Regeneron deal : PARIS (Thomson Financial) - French biotech company Cellectis said it will receive an upfront payment of $12.45 million from Regeneron Pharmaceuticals Inc for an agreement to allow the U.S. company the use of Cellectis...
Register for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Level 2 Scope and Average True Range.
Get the Latest Regeneron Pharmaceuticals stock Price, quotes, trades and FREE Regeneron Pharmaceuticals stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Regeneron Pharmaceuticals (REGN) and other NASDAQ Stock Market listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards.